ERBB2 and ductal breast carcinoma in situ: These data suggest that the p63/Her2/neu coexpressing cells represent a subgroup that is unique to comedo-DCIS, and that the classic Her2-overexpressors and atypical basal-like p63+/Her2+ cells potentially emerge from distinct precursor subsets.